Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Spinifex Pharmaceuticals designs novel angiotensin AT2 receptor antagonists

Aug. 13, 2013

Synergistic effects on cognition seen with ZSET-1446 and galantamine, rivastigmine and memantine

Aug. 13, 2013

Suven Life Sciences characterizes agents acting on serotonin receptors for Alzheimer's disease

Aug. 12, 2013

Preclinical evaluation of cell therapy to improve cognitive function after brain irradiation

Aug. 12, 2013

Lu-AE-58054 is a safe and effective add-on therapy to acetylcholinesterase inhibitors

Aug. 9, 2013

Ajinomoto presents new TRPA1 antagonists

Aug. 9, 2013

Evidence for the success of a DNA vaccine against AD in non-human primates

Aug. 9, 2013

gIcare Pharma begins phase II trial of GIC-1001 in sedation-free colonic analgesia

Aug. 8, 2013

A small-molecule PDE7 inhibitor for the treatment of neurodegenerative disorders described

Aug. 8, 2013

Avagacestat studied in predementia Alzheimer's disease in phase II trial

Aug. 8, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...